Encompass Health (EHC)
Market Price (9/14/2025): $125.86 | Market Cap: $12.7 BilSector: Health Care | Industry: Health Care Facilities
Encompass Health (EHC)
Market Price (9/14/2025): $125.86Market Cap: $12.7 BilSector: Health CareIndustry: Health Care Facilities
Investment Highlights
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 19% | Trading close to highsDist 52W High is -0.6%, Dist 3Y High is -0.6% | Expensive valuation multiplesP/EPrice/Earnings or Price/(Net Income) is 24x |
Low stock price volatilityVol 12M is 27% |
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 19% |
Low stock price volatilityVol 12M is 27% |
Trading close to highsDist 52W High is -0.6%, Dist 3Y High is -0.6% |
Expensive valuation multiplesP/EPrice/Earnings or Price/(Net Income) is 24x |
Market Valuation
9/14/25 | 2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|---|
Share Price CYE | $125.86 | $91.90 | $66.03 | $58.63 | $50.15 |
Market Cap CYE ($ Bil) | 12.7 | 9.2 | 6.6 | 5.8 | 5.0 |
Total Debt ($ Bil) | 2.7 | 2.7 | 2.9 | 3.0 | 3.5 |
Total Cash ($ Bil) | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
Enterprise Value ($ Bil) | 15.2 | 11.9 | 9.5 | 8.8 | 8.5 |
Valuation Ratios | |||||
P/S TTM | 2.2 | 1.7 | 1.4 | 1.4 | 1.3 |
P/EBIT TTM | 12.8 | 10.4 | 8.8 | 9.5 | 7.7 |
P/E TTM | 24.2 | 20.2 | 18.9 | 21.9 | 12.5 |
Sector Ratios | |||||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 | 4.5 | 7.3 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 | -1.3 | -2.9 |
P/E TTM (Sector) | -1.9 | -1.6 | -1.5 | -1.4 | -2.9 |
9/14/25 | 2024 | 2023 | |
---|---|---|---|
Share Price CYE | $125.86 | $91.90 | $66.03 |
Market Cap CYE ($ Bil) | 12.7 | 9.2 | 6.6 |
Total Debt ($ Bil) | 2.7 | 2.7 | 2.9 |
Total Cash ($ Bil) | 0.1 | 0.1 | 0.1 |
Enterprise Value ($ Bil) | 15.2 | 11.9 | 9.5 |
Valuation Ratios | |||
P/S TTM | 2.2 | 1.7 | 1.4 |
P/EBIT TTM | 12.8 | 10.4 | 8.8 |
P/E TTM | 24.2 | 20.2 | 18.9 |
Sector Ratios | |||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 |
P/E TTM (Sector) | -1.9 | -1.6 | -1.5 |
Business Description
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Show more
Price Returns Compared
Expand for Detailed View2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
---|---|---|---|---|---|---|---|
Returns | |||||||
EHC Return | 21% | -20% | 17% | 13% | 39% | 37% | 144% |
Peers Return | 9% | 42% | -12% | 13% | 31% | 17% | 138% |
S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 12% | 104% |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: HCA, DGX, UHS, SEM, THC. See EHC Returns vs. Peers.
[3] 2025 data is for the year up to 9/12/2025 (YTD)
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Encompass Health
Financials
Median | |
---|---|
Name | |
Mkt Price | 188.12 |
Mkt Cap | 15.2 |
Rev LTM | 13,491 |
Op Inc LTM | 1,643 |
FCF LTM | 1,063 |
FCF 3Y Avg | 870 |
CFO LTM | 1,789 |
CFO 3Y Avg | 1,510 |
Growth & Margins
Median | |
---|---|
Name | |
Rev Chg LTM | 8.0% |
Rev Chg 3Y Avg | 4.6% |
Rev Chg Q | 8.0% |
QoQ Delta Rev Chg LTM | 1.9% |
Op Mgn LTM | 14.6% |
Op Mgn 3Y Avg | 13.4% |
QoQ Delta Op Mgn LTM | 0.3% |
CFO/Rev LTM | 13.9% |
CFO/Rev 3Y Avg | 12.9% |
FCF/Rev LTM | 7.6% |
FCF/Rev 3Y Avg | 6.1% |
Valuation
Median | |
---|---|
Name | |
Mkt Cap | 15.2 |
P/S | 1.1 |
P/EBIT | 9.2 |
P/E | 14.1 |
P/CFO | 7.7 |
Total Yield | 7.7% |
Dividend Yield | 0.6% |
FCF Yield 3Y Avg | 6.5% |
D/E | 0.4 |
Net D/E | 0.4 |
Returns
Median | |
---|---|
Name | |
1M Rtn | 3.5% |
3M Rtn | 6.9% |
6M Rtn | 21.0% |
12M Rtn | 11.1% |
3Y Rtn | 97.5% |
1M Excs Rtn | 3.0% |
3M Excs Rtn | -1.8% |
6M Excs Rtn | 4.0% |
12M Excs Rtn | -6.0% |
3Y Excs Rtn | 29.0% |
Comparison Analyses
Returns Analyses
Earnings Returns History
Expand for MoreForward Returns | |||
---|---|---|---|
Earnings Date | 1D Returns | 5D Returns | 21D Returns |
8/4/2025 | 4.0% | 7.3% | 12.9% |
4/24/2025 | 11.8% | 14.3% | 17.2% |
2/6/2025 | 1.3% | 1.6% | 0.5% |
10/28/2024 | 7.4% | 7.7% | 11.5% |
8/5/2024 | -5.6% | -3.1% | 4.4% |
4/24/2024 | -0.1% | 0.1% | 2.1% |
2/7/2024 | 0.9% | 0.8% | 5.1% |
10/26/2023 | -0.6% | 3.3% | 6.4% |
... | |||
SUMMARY STATS | |||
# Positive | 15 | 19 | 15 |
# Negative | 9 | 5 | 9 |
Median Positive | 2.7% | 3.5% | 8.1% |
Median Negative | -0.8% | -3.1% | -6.2% |
Max Positive | 11.8% | 14.3% | 28.3% |
Max Negative | -5.6% | -5.4% | -12.4% |
SEC Filings
Expand for MoreReport Date | Filing |
---|---|
6302025 | 10-Q 6/30/2025 |
3312025 | 10-Q 3/31/2025 |
12312024 | 10-K 12/31/2024 |
9302024 | 10-Q 9/30/2024 |
6302024 | 10-Q 6/30/2024 |
3312024 | 10-Q 3/31/2024 |
12312023 | 10-K 12/31/2023 |
9302023 | 10-Q 9/30/2023 |
6302023 | 10-Q 6/30/2023 |
3312023 | 10-Q 3/31/2023 |
12312022 | 10-K 12/31/2022 |
9302022 | 10-Q 9/30/2022 |
6302022 | 10-Q 6/30/2022 |
3312022 | 10-Q 3/31/2022 |
12312021 | 10-K 12/31/2021 |
9302021 | 10-Q 9/30/2021 |
Insider Activity
Expand for MoreOwner | Title | Filing Date | Action | Price | Shares | TransactedValue | Value ofHeld Shares | Form | |
---|---|---|---|---|---|---|---|---|---|
0 | Tuer Patrick William | EVP, Chief Operating Officer | 8272025 | Sell | 123.59 | 1,020 | 126,062 | 2,329,177 | Form |
1 | Charbonneau Elissa Joy | Chief Medical Officer | 5072025 | Sell | 116.61 | 4,279 | 498,974 | 1,394,429 | Form |
2 | Price Andrew L | Chief Accounting Officer | 2132025 | Sell | 98.29 | 5,042 | 495,578 | 6,798,130 | Form |
External Quote Links
Y Finance | Barrons |
TradingView | Morningstar |
SeekingAlpha | ValueLine |
Motley Fool | Robinhood |
CNBC | Etrade |
MarketWatch | Unusual Whales |
YCharts | Perplexity Finance |
FinViz |